XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:        
Net (decrease) increase in net assets resulting from operations $ 30,722 $ 7,278 $ (11,491) $ 6,799
Adjustments to reconcile net (decrease) increase in net assets resulting from operations to net cash provided by operating activities:        
Amortization of debt issuance costs 600 500 1,973 1,272
Net realized loss on investments     31,820 31,422
Net realized loss on extinguishment of debt 1,261 0 2,037 0
Net unrealized depreciation (appreciation) on investments (40,517) (29,335) 13,796 (864)
Purchase of investments     (153,805) (121,211)
Principal payments received on investments     204,604 120,448
Payment-in-kind (“PIK”) interest on investments     (1,192) (2,114)
Proceeds from sale of investments     5,317 157
Warrants received in settlement of fee income     (71) (359)
Accrued interest converted to common stock     125 0
Equity received in settlement of interest and fee income     (3,209) 0
Changes in assets and liabilities:        
Decrease (increase) in end-of-term payments     2,495 (1,088)
Decrease in unearned income     (2,883) (2,381)
Increase in other assets     (927) (201)
Decrease in base management fee payable     (124) (27)
Net cash provided by operating activities     87,055 30,073
Increase in interest receivable     (1,803) (775)
Increase (decrease) in other accrued expenses     393 (1,005)
Cash flows from financing activities:        
Proceeds from issuance of common stock, net of offering costs     14,182 47,527
Advances on Credit Facilities     15,000 50,000
Repayment of Credit Facilities     0 (70,000)
Debt issuance costs     (6,037) (3,334)
Distributions paid     (39,083) (34,310)
Net cash used in financing activities     (57,016) (19,147)
Net increase in cash, cash equivalents and restricted cash     30,039 10,926
Proceeds from issuance of 2030 Convertible Notes     40,000 0
Cash, cash equivalents and restricted cash:        
Beginning of period     100,868 75,722
End of period 130,907 86,648 130,907 86,648
Supplemental disclosure of cash flow information:        
Cash paid for interest     22,828 22,770
Supplemental non-cash operating and financing activities:        
Refinanced debt investment balances     46,250 19,540
Warrant investments received and recorded as unearned income     278 1,269
Debt converted to common stock     17,250 0
Distributions payable 14,624 12,475 14,624 12,475
End-of-term payments receivable     11,033 12,905
Non-cash income     12,008 9,448
Cash 84,662 52,302 84,662 52,302
Investments in money market funds 43,828 31,080 43,828 31,080
Restricted investments in money market funds 2,417 3,266 2,417 3,266
Total cash, cash equivalents and restricted cash $ 130,907 $ 86,648 130,907 86,648
Asset-backed Notes 2022 [Member]        
Cash flows from financing activities:        
Repayment of note     $ (81,078) $ (9,030)